Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cirillo

Showing results (441-450 of 477) with videos related to

Pageof 48
Sort By:
Eclinicalmedicine|April 18, 2020
Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countriesValérie Schwœbel, Arnaud Trébucq, Zacharie Kashongwe, et al.
Molecular Therapy. Methods & Clinical Development|January 26, 2023
Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replicationRichard Dambra, Andrea Matter, Kaitlynn Graca, et al.
Microbiology Spectrum|December 12, 2025
Clinical evaluation of a commercial culture-free targeted next-generation sequencing test for diagnosis of drug-resistant tuberculosisPaolo Miotto, Rebecca E Colman, Andrea M Cabibbe, et al.
Bone Marrow Transplantation|September 27, 2016
Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantationA Forcina, R Baldan, V Marasco, et al.
International Journal of Systematic and Evolutionary Microbiology|August 9, 2016
Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacteriumabscessus subsp. bolletii and designation of Mycobacteriumabscessus subsp. massiliense comb. novEnrico Tortoli, Thomas A Kohl, Barbara A Brown-Elliott, et al.
International Journal of Mycobacteriology|March 12, 2021
Multicenter evaluation of xpert MTB/RIF ultra tests reporting detection of "Trace" of <i>Mycobacterium tuberculosis</i> DNAEster Mazzola, Paola Dal Monte, Claudio Piersimoni, et al.
Scientific Reports|February 19, 2020
Screening of inmates transferred to Spain reveals a Peruvian prison as a reservoir of persistent Mycobacterium tuberculosis MDR strains and mixed infectionsEstefanía Abascal, Marta Herranz, Fermín Acosta, et al.
IJTLD Open|March 17, 2025
Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacyL Kuksa, C Andrejak, B Haecker, et al.
The European Respiratory Journal|May 2, 2009
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statementU Mack, G B Migliori, M Sester, et al.
Mbio|August 31, 2017
The New Xpert MTB/RIF Ultra: Improving Detection of <i>Mycobacterium tuberculosis</i> and Resistance to Rifampin in an Assay Suitable for Point-of-Care TestingSoumitesh Chakravorty, Ann Marie Simmons, Mazhgan Rowneki, et al.
Pageof 48

Showing results (441-450 of 477) with videos related to

Sort By:
Pageof 48
Eclinicalmedicine|April 18, 2020
Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countriesValérie Schwœbel, Arnaud Trébucq, Zacharie Kashongwe, et al.
Molecular Therapy. Methods & Clinical Development|January 26, 2023
Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replicationRichard Dambra, Andrea Matter, Kaitlynn Graca, et al.
Microbiology Spectrum|December 12, 2025
Clinical evaluation of a commercial culture-free targeted next-generation sequencing test for diagnosis of drug-resistant tuberculosisPaolo Miotto, Rebecca E Colman, Andrea M Cabibbe, et al.
Bone Marrow Transplantation|September 27, 2016
Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantationA Forcina, R Baldan, V Marasco, et al.
International Journal of Systematic and Evolutionary Microbiology|August 9, 2016
Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacteriumabscessus subsp. bolletii and designation of Mycobacteriumabscessus subsp. massiliense comb. novEnrico Tortoli, Thomas A Kohl, Barbara A Brown-Elliott, et al.
International Journal of Mycobacteriology|March 12, 2021
Multicenter evaluation of xpert MTB/RIF ultra tests reporting detection of "Trace" of <i>Mycobacterium tuberculosis</i> DNAEster Mazzola, Paola Dal Monte, Claudio Piersimoni, et al.
Scientific Reports|February 19, 2020
Screening of inmates transferred to Spain reveals a Peruvian prison as a reservoir of persistent Mycobacterium tuberculosis MDR strains and mixed infectionsEstefanía Abascal, Marta Herranz, Fermín Acosta, et al.
IJTLD Open|March 17, 2025
Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacyL Kuksa, C Andrejak, B Haecker, et al.
The European Respiratory Journal|May 2, 2009
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statementU Mack, G B Migliori, M Sester, et al.
Mbio|August 31, 2017
The New Xpert MTB/RIF Ultra: Improving Detection of <i>Mycobacterium tuberculosis</i> and Resistance to Rifampin in an Assay Suitable for Point-of-Care TestingSoumitesh Chakravorty, Ann Marie Simmons, Mazhgan Rowneki, et al.
Pageof 48